Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

Motivations to initiate injectable hydromorphone and diacetylmorphine treatment: A qualitative study of patient experiences in Vancouver, Canada

This study examines peoples’ motivations for accessing HDM/DAM treatment and situates these within the social and structural context that shapes treatment delivery by employing the concept of structur
Original research | 2020
Harm reduction, Safer supply, Equity, About PWUD, Social benefits

Not what the doctor ordered: Motivations for nonmedical prescription drug use among people who use illegal drugs

This study provides further evidence of the harm reducing motives for Nonmedical Prescription Drug Use (NMPDU) among people who use illegal drugs in community and prison settings in Wales, UK.
Original research | 2020
Withdrawal, Safer supply, Equity, Advocacy, About PWUD, Legal system/law enforcement, Substitution/OAT, Diversion

Opioid agonist treatment and the process of injection drug use initiation

Preliminary evidence suggests that OAT may disrupt the social communicability of injection drug use (IDU) practices by established PWID.
Original research | 2019
Evidence base, Safer supply, Illegal drugs

Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities

The aim of this study was to examine perceptions of (supervised) injectable opioid agonist treatment (iOAT) (described as ‘an opioid similar to heroin self-injected at a clinic several times a day’) a
Original research | 2020
Policy/Regulatory, Safer supply, About PWUD, Barriers and enablers

Portrait du matériel d'injection et d'inhalation de drogues remis par les directions de santé publique aux centres d'accès du Québec : 2016-2017 à 2018-2019

Présente une analyse comparative des quantités de matériel remis par les directions de santé publique aux 1 239 centres d’accès au matériel d’injection.
Report | 2021
Harm reduction, Outcomes, Illegal drugs, Social benefits

Prescribing drug of choice to opiate dependent drug users: A comparison of clients receiving heroin with those receiving injectable methadone at a West London drug clinic

Compare outcomes between prescribed methadone and heroin
Original research | 2001
Evidence base, Safer supply, Outcomes, Crime, Substitution/OAT

Prolonged-release opioid agonist therapy: qualitative study exploring patients’ views of 1-week, 1-month, and 6-month buprenorphine formulations

To understand which durations of prolonged-release buprenorphine patients prefer
Original research | 2019
Evidence base, Wrap-around services, Safer supply, Social services, Barriers and enablers, Crime, Substitution/OAT, Social benefits, Stigma

Saving Lives. Changing Lives. Findings from an Evaluation of London’s Temporary Overdose Prevention Site (TOPS)

Process and outcome evaluation of the site's first six months
Report | 2019
Overdose, Harm reduction, Wrap-around services, Advocacy, About prescribers, About PWUD, Social services, Barriers and enablers, Outcomes, Crime, Illegal drugs, Drug checking, Stigma, SCS/OPS

The community impact of RIOTT, a medically supervised injectable maintenance clinic in south London

Investigates the impact on the local community of a Medically Supervised Injectable Maintenance Clinic
Original research | 2010
Crime, Illegal drugs, SCS/OPS

The virtual disappearance of injectable opioids for heroin addiction under the ‘British System’

Injectable opioids were prescribed unsupervised under the ‘British System’ for heroin dependence.
Original research | 2010
Policy/Regulatory

A Perspective on Opioid Pharmacotherapy: Where We Are and How We Got Here

Looks at which medications are used to treat opioid addiction and the reasons influencing their choice
Commentary | 2016
Evidence base, Policy/Regulatory, About prescribers

Assessing the determinants of completing OAT induction and long-term retention: A population-based study in British Columbia, Canada

Induction into opioid agonist treatment (OAT) features the highest risk of mortality throughout the treatment course, and greatest risk of discontinuation.
Original research | 2021
Evidence base, Advocacy, Outcomes, Substitution/OAT, Transitions in care/treatment

Buprenorphine-naloxone microdosing: Tool for opioid agonist therapy induction

To raise awareness of alternative techniques that can facilitate buprenorphine-naloxone treatment for opioid use disorder.
Original research | 2020
Clinical guidance, Harm reduction, About prescribers, Substitution/OAT

Comparison of Characteristics of Deaths From Drug Overdose Before vs During the COVID-19 Pandemic in Rhode Island

Were there changes in the rate and characteristics of deaths from drug overdose before vs during the COVID-19 pandemic in Rhode Island?
Original research | 2021
Overdose, Mortality, Housing, Illegal drugs, Sex/Gender , Mental health

COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings

Commentary | 2020
Harm reduction, Safer supply, Housing, Illegal drugs

Development and assessment of a community-based screening tool for mental health disorders among people who inject drugs

The objectives of this study were to design and assess a quick screening tool (QST) that community-based organisations (CBO) could routinely apply to a Vietnamese population of people who inject drugs
Original research | 2021
Wrap-around services, About PWUD, Social services, Illegal drugs, Peer/PWLLE program involvement, Mental health

Drug Checking Services for People Who Use Drugs: A Systematic Review

We sought to identify and synthesize literature on the following domains: (a) influence of drug checking services on behaviour of people who use drugs; (b) monitoring of drug markets by drug checking
Lit review | 2021
Harm reduction, About PWUD, Barriers and enablers, Illegal drugs, Drug checking

Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario

To evaluate established opioid addiction treatment programs that use traditional healing in combination with buprenorphine-naloxone maintenance treatment in 6 First Nations communities in the Sioux Lo
Original research | 2017
Evidence base, Policy/Regulatory, Wrap-around services, Safer supply, About prescribers, Social services, Outcomes, Indigenous, Rural/remote, Substitution/OAT

Expanding access to diacetylmorphine and hydromorphone for people who use opioids in Canada

This commentary explores the current state of policy and practice for diacetylmorphine and hydromorphone as opioid substitution options in Canada, outlines the rationale for rapid expansion of access,
Commentary | 2020
Policy/Regulatory, Advocacy

Feasibility and acceptability of a digital health intervention to promote engagement in and adherence to medication for opioid use disorder

The goal of this study was to elucidate key elements surrounding the acceptability/feasibility and structure of an interactive computer- and text message–delivered personalized feedback intervention f
Original research | 2021
About PWUD, Substitution/OAT, Digital health

Affiner votre recherche

Mots clés
Format
Région